baber/WOPTO huggingface dataset:
Patent WO-2020163362-A1 (WO)
Inventor: SELTZER RICHARD
IPC: A61B5/16
Filed: 2020-02-04
Abstract: L'invention concerne un système qui comprend un dispositif de collier comprenant un composant de masquage de son, le dispositif de collier comprenant un ou plusieurs capteurs de dispositif de collier pour détecter des données physiologiques d'un animal. Le système comprend un ou plusieurs capteurs environnementaux configurés pour détecter des données environnementales de l'environnement de l'animal et pour transmettre les données environnementales au dispositif de collier. Le dispositif de collier comprend une ou plusieurs applications s'exécutant sur au moins un processeur pour détecter une occurrence d'un ou de plusieurs événements à l'aide d'au moins l'une des données physiologiques, des données environnementales et des données de résultat. La ou les applications sont configurées pour utiliser des informations du ou des événements pour sélectionner un signal de masquage de son pour une distribution après l'occurrence du ou des événements. Le système comprend un composant de masquage de son pour délivrer le signal de masquage de son.
Patent WO-2020176811-A1 (WO)
Inventor: NIIMI HIROAKI
IPC: H01L21/8238
Filed: 2020-02-27
Abstract: A semiconductor device includes a first raised feature in a NFET region on a substrate, a first n-type doped epitaxial semiconductor material grown on the first raised feature, the first n-type doped epitaxial material having a first upward facing surface and a first downward facing surface, a first contact metal on the first downward facing surface, and a second contact metal on the first upward facing surface. The device further includes a second raised feature in a PFET region on the substrate, a second p-type doped epitaxial semiconductor material grown on the second raised feature, the second p-type doped epitaxial material having a second upward facing surface and a second downward facing surface, a third contact metal on the second downward facing surface, and a fourth contact metal on the second upward facing surface, wherein the fourth contact metal is different from the second contact metal.
Patent WO-2020190831-A1 (WO)
Inventor: HOLLIS ANDY
IPC: C08J5/04
Filed: 2020-03-16
Abstract: A three-dimensional component is produced in a simplified molding operation. Expandable substrates, which are referred to as blanks, are created by compressing thermobonded nonwovens after heating the binder material above its melting temperature, and then cooling the compressed nonwovens so that the binder material hardens and holds the fibers of the nonwoven together in a compressed configuration with stored kinetic energy. Boards can be formed by laminating two or more blanks together and/or by laminating the blanks with other materials, including non-expendable materials. A mold for the component to be manufactured can be partially filled with a number of boards ( or blanks) in a stacked, vertically, adjacent or even random orientation. In addition, the boards or blanks may be cut to create desired shapes of parts that can be placed in the mold.
Patent WO-2020191086-A1 (WO)
Inventor: LIPSON MICHAL
IPC: H01S3/098
Filed: 2020-03-18
Abstract: Disclosed are devices, methods, and systems for controlling output of a laser. An example device can comprise a first portion comprising a gain element and a second portion comprising a silicon material. The second portion can comprise a waveguide configured to receive light from the gain element, an optical resonator configured to at least partially reflect light back to the gain element via the waveguide, and a first tuning element configured to tune a resonant frequency of the optical resonator.
Patent WO-2020198281-A1 (WO)
Title: Plk1 inhibitors and psa levels in prostate cancer
Inventor: ERLANDER MARK
IPC: A61K31/519
Filed: 2020-03-25
Abstract: Provided is a method comprising recommending treatment of a prostate cancer patient with a polo-like kinase- 1 (PLK1) inhibitor if the patient has rising prostate specific antigen (PSA) levels. Also provided is a method comprising measuring prostate specific antigen (PSA) levels in at least two samples from a prostate cancer patient, the samples obtained from the patient at different times; and recommending treatment of the patient with a PLK1 inhibitor if the PSA levels in the samples increase over time, or not recommending treatment of the patient with a PLK1 inhibitor if the PSA levels in the samples do not increase over time. Additionally provided is a method comprising recommending treatment of a PLK1 inhibitor to a patient having a prostate cancer that has an altered androgen receptor that does not require ligand for activation.
Patent WO-2020263379-A1 (WO)
Inventor: L'HOSTIS JACQUELINE
IPC: C08G77/46
Filed: 2020-04-06
Abstract: A foam control agent comprising a linear polyorganosiloxane-polyoxyalkylene block copolymer comprising a single block of polyorganosiloxane having a DP of from 10 to 200 and a single block polyoxyalkylene block having a DP of from 2 to 60.
Patent WO-2020242624-A1 (WO)
Inventor: CHHABRA SHALENDRA
IPC: G06Q10/10
Filed: 2020-04-16
Abstract: The techniques disclosed herein improve existing systems by automatically generating summaries of shared content based on a contextual analysis of a user's engagement with an event. User activity data from a number of sensors and other contextual data, such as scheduling data and communication data, can be analyzed to determine a user's level of engagement of an event. A system can automatically generate a summary of any shared content the user may have missed during a time period that the user was not engaged with the event. For example, if a user becomes distracted or is otherwise unavailable during a presentation, the system can provide a summary of salient portions of content that was shared during the time of the user's inattentive status, such as, but not limited to, key topics, tasks, shared files, an excerpt of a transcript of a presentation or any salient sections of a shared video.
Patent WO-2020219809-A1 (WO)
Inventor: CUNNINGHAM AARON
IPC: H04R5/02
Filed: 2020-04-24
Abstract: This disclosure describes, in part, soundproof covers for voice-controlled devices. For instance, a first portion of a soundproof cover may include a soundproof material that does not allow outside sound to travel to microphone(s) of a voice-controlled device. A second portion of the soundproof cover may include a material and/or openings that allows interior sound output by speaker(s) of the voice-controlled device to travel outside of the soundproof cover. In some instances, such as when the voice-controlled device includes a display, a third portion of the soundproof cover may include material and/or an opening that allows the display to be visible.
Patent WO-2020232051-A1 (WO)
Title: Anticorps se liant à csf-1r et son utilisation
Inventor: CHEN MINGJIU
IPC: C07K16/30
Filed: 2020-05-13
Abstract: La présente invention concerne un anticorps monoclonal isolé ou un fragment de celui-ci se liant à l'antigène, lequel se lie spécifiquement à CSF-1R. L'invention concerne également une molécule d'acide nucléique codant pour l'anticorps ou le fragment de celui-ci se liant à l'antigène, un vecteur d'expression, une cellule hôte et un procédé d'expression de l'anticorps ou du fragment de celui-ci se liant à l'antigène. La présente invention concerne en outre une molécule bispécifique, un immunoconjugué, un récepteur antigénique chimérique, un virus oncolytique et une composition pharmaceutique comprenant l'anticorps ou le fragment de celui-ci se liant à l'antigène, ainsi qu'un procédé de traitement faisant appel audit anticorps ou audit fragment de celui-ci se liant à l'antigène.
Patent WO-2020237216-A1 (WO)
Title: Method for cold atmospheric plasma exosome therapy
Inventor: CANADY JEROME
IPC: A61K35/17
Filed: 2020-05-22
Abstract: A method for bioengineering exosomes for cancer treatment. The method comprises the steps of isolating target tumor cells from a tissue sample, culturing the isolated target tumor cells, treating the cultured target tumor cells with cold atmospheric plasma to release exosomes from the target tumor cells, and collecting the released exosomes. The step of culturing the target tumor cells may comprise seeding the isolated target tumor cells in wells and incubating the target tumor cells in a culture media, for example, for 24 hours. The culture media may comprise Dulbecco's Modified Eagle Medium, an antibiotic and 10% fetal bovine serum. The step of culturing the target tumor cells may further comprise replacing the culture media with Dulbecco's Modified Eagle Medium and an antibiotic. The target tumor cells may comprise, for example, one of U87 cells, KKU-055 cells and triple negative MDA-MB-231 cells.
Patent WO-2020243723-A1 (WO)
Inventor: MAGNESS R JOSEPH
IPC: B29C64/386
Filed: 2020-06-01
Abstract: A dental appliance (10) is disclosed. The appliance (10) may include an arcuate base (20) shaped to extend along at least a portion of an upper dental arch of a patient and match with a custom fit at least certain maxillary teeth (14) of the patient. The appliance (10) may further include a tongue-retention feature (98). The tongue-retention feature (98) may connect to the arcuate base (20) and comprise a palatal portion (110) and a sublingual portion (112). The sublingual portion (112) may cooperate with the palatal portion (110) to form a cavity shaped to receive an anterior portion of a tongue (100) of the patient therewithin. The tongue-retention feature (98) may have an exterior surface (118) custom-formed to match at least a portion of a hard palate (114) of the patient.
Patent WO-2020247496-A1 (WO)
Inventor: BEATTY JOEL WORLEY
IPC: C07D231/00
Filed: 2020-06-03
Abstract: Compounds that inhibit PI3Kγ, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by PI3Kγ.
Patent WO-2021021286-A1 (WO)
Inventor: XU ZHANPING
IPC: G01S17/894
Filed: 2020-06-05
Abstract: Adaptive phase unwrapping for a time-of-flight camera. A scene is illuminated with modulation light having two or more frequencies that do not have a common integer denominator. The modulation light that is reflected off objects within the scene is received at a sensor array. The received modulation light is then processed and weighted in the complex domain to determine unwrapped phases for each of the two or more frequencies of modulation light.
Patent WO-2020257165-A1 (WO)
Inventor: CUI JINGRONG JEAN
IPC: A61P35/00
Filed: 2020-06-16
Abstract: The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
Patent WO-2020264130-A1 (WO)
Title: Oral care device for intubation
Inventor: FLINT DERRICK
IPC: A61M16/04
Filed: 2020-06-25
Abstract: An oral care device for use during intubation. The device can include a first guard, a second guard, a first extension, a second extension, and a central pathway. The first guard can be configured for insertion into an oral cavity of a patient. The first extension and the second extension can each extend from the first guard and can together be configured to engage a dentition of a patient. The second guard can be configured to surround and engage an exterior of an oral cavity of the patient.
Patent WO-2021016035-A1 (WO)
Title: Evaluating the safety performance of vehicles
Inventor: BALAKRISHNAN HARI
IPC: G01M17/00
Filed: 2020-07-16
Abstract: Among other things, safety performance of vehicles is monitored or evaluated, or both. Sensor data is received from one or more sensors at a vehicle. One or more risk sources encountered by the vehicle during a period of operation of the vehicle are identified based on the sensor data. One or more safety events experienced by the vehicle during the period of operation are identified based on the sensor data. A risk of a safety event experienced by the vehicle during the period of operation is determined based on the one or more risk sources. A safety performance of the vehicle during the period of the vehicle during the period of operation of the vehicle is determined based on the one or more safety events and the risk.
Patent WO-2021021473-A1 (WO)
Inventor: CRUZ CARLOS A
IPC: B29C49/00
Filed: 2020-07-20
Abstract: Ethylene-based polymers having a density of 0.952 to 0.965 g/cm 3 , a high load melt index (HLMI) from 5 to 25 g/10 min, a weight-average molecular weight from 275,000 to 450,000 g/mol, a number-average molecular weight from 15,000 to 40,000 g/mol, a viscosity at HLMI from 1400 to 4000 Pa-sec, and a tangent delta at 0.1 sec -1  from 0.65 to 0.98 degrees. These polymers have the processability of chromium-based resins, but with improved stress crack resistance, and can be used in large-part blow molding applications.
Patent WO-2021041632-A1 (WO)
Title: System and method for augmented reality visualization of benign paroxysmal position vertigo (bppv) disorder
Inventor: TEIXIDO MICHAEL
IPC: A61B5/00
Filed: 2020-08-27
Abstract: According to one aspect, a system for augmented reality visualization of benign paroxysmal position vertigo (BPPV) disorder. The system includes a camera configured to capture an image sequence, a processing unit configured to generate at least one virtual model of an inner ear, wherein the at least one virtual model of the inner ear comprises an accurate anatomical representation of a real human inner ear; and a display configured to display the at least one virtual model of the inner ear over the image sequence.
Patent WO-2021101615-A1 (WO)
Inventor: CHIU MICHAEL
IPC: G02B27/62
Filed: 2020-09-03
Abstract: A robotic system (402) automatically aligns, and/or tests alignment of, a lens (704, 804) to a digital camera (706, 806) or other workpiece (700, 800). The system (402) includes an optical target (106), an intermediate lens (318) and a plurality of collimators (400) peripheral to the intermediate lens (318) to accommodate a wide range of fields of view (702, 802) of the workpieces (700, 800), without requiring changes in equipment hardware. When manufacturing or testing a workpiece (700, 800) with a relatively narrow field of view (702), the entire field of view (702) of the workpiece (700) can be filled with a view of the target (106) through the intermediate lens (318), and the collimators (400) need not be used. However, when manufacturing or testing a camera having a relatively large field of view (802), the intermediate lens (318) is used to fill a central portion (1102) of the field of view (802) with an image of the target (106), and the collimators (400) are used to fill a remaining portion of the field of view with images (1200-1204) of reticles (912).
Patent WO-2022055475-A1 (WO)
Title: Determinations of characteristics from biometric signals
Inventor: WEI JISHANG
IPC: G16H50/70
Filed: 2020-09-08
Abstract: An example system includes a plurality of biometric sensors to generate a plurality of signals. The system includes a feature engine to generate a plurality of feature vectors from the plurality of signals. The system includes a classifier engine to generate a plurality of decision vectors based on the plurality of feature vectors. The system includes an attention engine to weight the plurality of feature vectors and the plurality of decision vectors and determine a characteristic of a user based on the weighted feature and decision vectors.
Patent WO-2021050782-A1 (WO)
Title: A horizontal feed storage system
Inventor: GREIVE RAYMOND
IPC: B65G33/24
Filed: 2020-09-10
Abstract: A horizontal feed storage system may comprise an elongated feed container having a length and a width, wherein the length is at least ten times greater than the width. The elongated feed container may have a fill opening through which the feed is deposited into the elongated feed container and a feed removal opening through which feed is removed from the elongated feed container. The elongated feed container may be movable. The elongated feed container may include multiple conveyance mechanisms disposed within the elongated feed container. The multiple conveyance mechanisms may include a first conveyance mechanism and a second conveyance mechanism, wherein the first conveyance mechanism may displace feed by moving the feed in a first direction away from the fill opening, and/or the second conveyance mechanism may displace feed by moving the feed in a second direction toward the feed removal opening.
Patent WO-2021061482-A1 (WO)
Title: Bi-directional single supply level shifter circuit
Inventor: MANOHAR SUJAN K
IPC: H03K19/0185
Filed: 2020-09-17
Abstract: A level shifter circuit included in a computer system may include bootstrap and feedback nodes. The level shifter circuit may discharge the feedback node in response to high-going transition on a received input signal generated using a first power supply signal. The level shifter circuit may also increase a voltage level of the bootstrap node in response to the high-going transition and charge the bootstrap node, in response to the discharge of the feedback node, to a voltage level of a second power supply signal that is different than a voltage level of the first power supply signal. The level shifter circuit may generate an output signal using the voltage levels of the feedback node and the second power supply signal.
Patent WO-2021061909-A1 (WO)
Inventor: HUANG YADONG
IPC: A61P25/28
Filed: 2020-09-24
Abstract: A method for reducing neuronal and synaptic degeneration or loss in a population of neuronal cells is provided as well as a method of treating an individual with a neurocognitive disorder. Aspects of the methods include modulating the level and/or activity of apolipoprotein E (apoE) in a population of neuronal cells where the modulating reduces the level and/or activity of an MHC pathway polypeptide in the population of neuronal cells.
Patent WO-2021067324-A1 (WO)
Inventor: CHENG WEI-CHIEH
IPC: A61K31/445
Filed: 2020-09-30
Abstract: Disclosed herein are novel uses of ADMDP stereoisomers or their derivatives for the manufacture of a medicament for treating Pompe disease. Accordingly, the present disclosure provides a method of treating Pompe disease in a subject. The method includes the step of, administering to the subject a therapeutically effective amount of a compound of formula (I), or a salt, an ester or a solvate thereof, wherein R1 and R2 are independently H or alkyl optionally substituted by -NH2 or -OH, so as to ameliorate, alleviate mitigate and/or prevent symptoms associated with the Pompe disease. According to certain embodiments of the present disclosure, the compound of formula (I) may serve a stabilizer of α-glucosidase via preventing its denaturalization of deactivation.
Patent WO-2021067518-A1 (WO)
Inventor: WU CHAOHONG
IPC: G01N21/95
Filed: 2020-10-01
Abstract: An inspection system is disclosed. The system includes a controller communicatively couplable with an inspection sub-system configured to receive illumination from a sample and generate image data. The controller includes one or more processors configured to execute program instructions causing the one or more processors to receive the image data, wherein the image data comprises at least one image, downsample the at least one image using bicubic interpolation or bilinear interpolation, transform the at least one image from a spatial domain to a frequency domain using a Fourier transform, filter frequencies higher than a threshold frequency from the at least one image, transform the at least one image from the frequency domain to the spatial domain using an inverse Fourier transform, and detect one or more flat-pattern defects in the at least one image.
Patent WO-2021067650-A1 (WO)
Inventor: SOHN LYDIA L
IPC: B01L3/00
Filed: 2020-10-02
Abstract: A microfluidic device for timed-release analysis of cells incubated in microenvironment nodes (TRAIN), comprising a microfluidic channel containing a cell culture medium, and configured with multiple nodes located in series along the fluidic flowpath of the channel, wherein each node comprises a surface patterned with a corresponding oligonucleotide probe and at each node is a cell labeled with a complementary oligonucleotide tag and immobilized at the node by hybridization of the tag with the probe.
Patent WO-2021126345-A1 (WO)
Title: Machine-learning-based additive manufacturing using manufacturing data
Inventor: NILAKANTAN PADMANABHAN
IPC: B33Y50/00
Filed: 2020-10-05
Abstract: Systems and methods for machine-learning-based additive manufacturing use a machine-learning model to process an input vector describing a new part transaction, thereby providing part optimization outputs and command initiation outputs to configure additive manufacturing of a new part. The machine-learning model is trained based on entries in a user experience database, each entry in the user experience database including data defining requirements for an additively manufactured part previously fabricated or attempted to be fabricated, specifications describing an additive manufacturing fabrication device, a selection of a raw material type fed to the fabrication device for fabrication of the additively manufactured part, a fabrication spatial orientation of the additively manufactured part within the fabrication device, a fabrication slicing resolution of the additively manufactured part, and a toolpath taken by the fabrication device in fabricating the additively manufactured part.
Patent WO-2021081087-A1 (WO)
Title: Thermal - and photo-assisted aftertreatment of nitrogen oxides
Inventor: KALAMARAS CHRISTOS
IPC: B01D53/94
Filed: 2020-10-21
Abstract: Systems and methods for treating automotive vehicle emissions on board an automotive vehicle include the use of waste heat recovery, electrochemical water splitting, photocatalytic water splitting, and selective catalytic reduction. Waste heat recovery is used to power electrochemical water splitting, or photocatalytic water splitting. Photons collected from a solar panel are used in photocatalytic water splitting, or in photo-assisted selective catalytic reduction. Hydrogen gas generated by water splitting is used in conjunction with catalytic reduction units to catalytically reduce NOx in an engine exhaust gas.
Patent WO-2021101741-A1 (WO)
Inventor: SEETHARAMAN NARAYANAN
IPC: G11C29/50
Filed: 2020-11-09
Abstract: In described examples, a storage cell ring includes circularly coupled storage cells. Each storage cell (201) includes a respective capacitor (Ccp) for generating a respective integrated voltage responsive to a respective duration a respective storage cell is selected, a respective thresholding converter (240) for generating a respective thresholded signal for indicating whether the respective integrated voltage has crossed a threshold, and respective selection circuitry (210) configured to generate a respective select signal responsive to select signals generated by a respective adjacent storage cells. The ring is coupled to an analog quantifier (140) for generating a conversion value (TDC-OUT<N:1>) responsive to the generated respective integrated voltage and a respective select signal. The ring is coupled to a loop counter (130) for generating a loop count value (TDC-OUT<M+3:N+1>) responsive to changes of values of at least some of the respective thresholded signals. The conversion value and the loop count value can comprise a time measurement (TDC-OUT<M+3+N:1>).